TY - JOUR
T1 - The clinical efficacy of a bovine lactoferrin/whey protein Ig-rich fraction (Lf/IgF) for the common cold: a double blind randomized study
AU - Vitetta, Luis
AU - Coulson, Samantha
AU - Beck, Shoshannah L
AU - Gramotnev, Helen
AU - Du, Sharon
AU - Lewis, Sophie
PY - 2013
Y1 - 2013
N2 - Objective: The aim of the study was to determine if a bovine lactoferrin/whey protein Ig-rich fraction (Lf/IgF) combination was effective in reducing the number of colds and in turn improving symptom recovery in a cohort of males and females that reported frequently contracting a cold. Design: A double blind randomized placebo-controlled clinical trial. Setting: One-hundred and twenty-six participants matched by age, BMI, dietary and physical parameters with self-reported frequent upper respiratory tract symptoms and infections were randomly assigned to receive 600. mg of Lf/IgF or a placebo daily for 90 days. Main outcome measures and results: A total of 90 participants (47 receiving the active and 43 placebo) completed the 90 day trial and 15 completed 45 days participation (6 in the active and 9 in the placebo group). The total number of colds recorded over the study period was 48 for the treatment group versus 112 for the placebo group (p
AB - Objective: The aim of the study was to determine if a bovine lactoferrin/whey protein Ig-rich fraction (Lf/IgF) combination was effective in reducing the number of colds and in turn improving symptom recovery in a cohort of males and females that reported frequently contracting a cold. Design: A double blind randomized placebo-controlled clinical trial. Setting: One-hundred and twenty-six participants matched by age, BMI, dietary and physical parameters with self-reported frequent upper respiratory tract symptoms and infections were randomly assigned to receive 600. mg of Lf/IgF or a placebo daily for 90 days. Main outcome measures and results: A total of 90 participants (47 receiving the active and 43 placebo) completed the 90 day trial and 15 completed 45 days participation (6 in the active and 9 in the placebo group). The total number of colds recorded over the study period was 48 for the treatment group versus 112 for the placebo group (p
UR - http://www.ncbi.nlm.nih.gov/pubmed/23642947
U2 - 10.1016/j.ctim.2012.12.006
DO - 10.1016/j.ctim.2012.12.006
M3 - Article
SN - 0965-2299
VL - 21
SP - 164
EP - 171
JO - Complementary Therapies in Medicine
JF - Complementary Therapies in Medicine
IS - 3
ER -